|
Schlüsselwörter: Medikament,
Arzneimittel, Therapie, Behandlung, Muraglitazar,
Pargluva, Insulinsensitizer, PPAR-Agonist, Diabetes,
Pioglitazon, Actos, Glitazone, Insulinresistenz,
Diabetes Mellitus, Troglitazon, Rosiglitazon, Avandia,
Sulfonylharnstoffe, Metformin und Hepatotoxizität.
|